PATHOLOGY AND TISSUE INFORMATICS CORE The Pathology and Tissue Informatics Core (PTIC) combines a centralized mechanism for expert tissue handling services and performance of tissue-based assays by highly qualified, experienced personnel with a state-of-the- art integrated informatics infrastructure which provides tools for 1) scheduling and tracking specimen collection, 2) histopathological and clinical annotation of acquired samples including virtual slide images and 3) maintaining linkage of genomic and other resultant translational data generated by Projects 1 through 4 proposed in this renewal with these samples. The PTIC will consent, collect, de-identify, process, bank and distribute annotated, high-quality breast tumor, blood and urine samples from patients participating in SPORE clinical trials and/or enrolled in the Vanderbilt Breast Tissue/Body Fluids Repository protocol, while protecting patient confidentiality by de-identification of specimens upon distribution. The PITC will provide investigators with specialized technical and interpretative histology services including expertise in developing, performing and evaluating immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assays, TIL assessments, tissue Q/A and preparation for nucleic acid extraction for sequencing-based assays and oversight on optimal utilization of each sample. Partnering of tissue services and Vanderbilt-Ingram Cancer Center (VICC) Research Informatics Shared Resource (RISR) unifies the expertise required to create the Triple Negative Breast Cancer (TNBC) Atlas Collaborative, a unique resource focused on TNBC cases interrogated in this renewal as well as prior SPORE grant cycles, that integrates translational data generated in multiple systems into a comprehensive resource of over 500 TNBC cases with subsequent local and public dissemination for secondary use of research data including submission to the American Association for Cancer Research (AACR) Project GENIE and NCI Genomic Data Commons (GDC).

Public Health Relevance

PATHOLOGY AND TISSUE INFORMATICS CORE The Pathology and Tissue Informatics Core (PTIC) is critical to the mission of Vanderbilt-Ingram Cancer Center (VICC) SPORE in Breast Cancer. This resource is devoted to clinical trial-related tissue collection, procurement for the Vanderbilt Breast Tissue and Body Fluids Repository and provision of specialized diagnostic and technical histopathology services to SPORE investigators. Partnering of pathology tissue services and VICC Research Informatics Shared Resource (RISR) unifies the expertise required to schedule and track tissue collections; link specimen-specific information to subsequent translational genomic and protein expression data; and create the Triple Negative Breast Cancer (TNBC) Atlas Collaborative, a unique resource that will have greater than 375 metastatic triple negative breast cancer cases which will be publicly disseminated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA098131-17A1
Application #
9791051
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
17
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Santos Guasch, Gabriela L; Beeler, J Scott; Marshall, Clayton B et al. (2018) p73 Is Required for Ovarian Follicle Development and Regulates a Gene Network Involved in Cell-to-Cell Adhesion. iScience 8:236-249
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Williams, Michelle M; Lee, Linus; Werfel, Thomas et al. (2018) Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell Death Dis 9:21
Hyman, David M; Piha-Paul, Sarina A; Won, Helen et al. (2018) HER kinase inhibition in patients with HER2- and HER3-mutant cancers. Nature 554:189-194
Luo, Na; Nixon, Mellissa J; Gonzalez-Ericsson, Paula I et al. (2018) DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer. Nat Commun 9:248
Sudhan, Dhivya R; Schwarz, Luis J; Guerrero-Zotano, Angel et al. (2018) Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial. Clin Cancer Res :
Werfel, Thomas A; Wang, Shan; Jackson, Meredith A et al. (2018) Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. Cancer Res 78:1845-1858
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Lee, Kyung-Min; Giltnane, Jennifer M; Balko, Justin M et al. (2017) MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation. Cell Metab 26:633-647.e7

Showing the most recent 10 out of 341 publications